thebench.bio #1 Ecosystem for the Bio-Tech Industry
All Clinical Trial Design questions

Question 9 of 9 Advanced Practical

Design a strategy to limit bias when blinding is impossible for a behavioral intervention.

Short answer

If participant blinding is impossible, protect randomization, outcome measurement and analysis. Bias can be reduced without pretending the intervention is blinded.

Why

Knowledge of allocation influences behavior, adherence, care delivery, co-interventions, ascertainment and reporting. These pathways need different controls: blinded assessors reduce measurement bias, while standardized delivery and objective outcomes reduce performance and detection bias.

How to work it through

  1. Use concealed random allocation, prespecified intervention manuals and fidelity checks.
  2. Choose blinded central assessors and objective endpoints when feasible.
  3. Measure expectations, co-interventions and adherence.
  4. Keep analysts masked to treatment labels until the locked analysis.
  5. Prespecify missing-data handling and sensitivity analyses reflecting plausible behavior-related bias.
  6. Report contamination and deviations transparently.

An example

A lifestyle trial cannot hide exercise assignments from participants, but can blind assessors evaluating treadmill performance, use the same visit schedule, and apply standardized scripts and an intention-aligned analysis.

Where the answer stops holding

An objective biomarker can still be affected by post-randomization co-treatment. Sham controls may be unethical or infeasible. Blinding an analyst does not correct an outcome defined differently between groups.

A strong answer covers

  • If participant blinding is impossible, protect randomization, outcome measurement and analysis
  • Bias can be reduced without pretending the intervention is blinded
  • Use concealed random allocation, prespecified intervention manuals and fidelity checks

Common mistakes

  • Saying that randomization eliminates every bias
  • Discarding participant-reported outcomes entirely
  • Failing to measure differential follow-up